ACETHealthcareMicro-Cap
Adicet Bio, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Adicet Bio, Inc. (ACET), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ACET insiders buying or selling?
Adicet Bio, Inc. insiders reported 9 open-market buys ($39.3M) and 35 sells ($16.9M) across 44 Form 4 filings — a net buying position of $22.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Apr 13, 2026)
Total Form 4 filings
44
SEC EDGAR
Insider filers
12
Insider buys (9)
$39.3M
Insider sells (35)
$16.9M
Insider sentiment
Net buyingNet insider flow of $22.4M in net buying.
Recent ACET insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Peter Kolchinsky | 10% Owner | Purchase | 223.6K | $7.17 | $1.6M |
| Apr 9, 2026 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 104.7K | $6.45 | $674.8K |
| Oct 11, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Purchase | 5.0M | $1.00 | $5.0M |
| Jun 7, 2024 | Michael Kauffman | Director | Sale | 5.9K | $1.43 | $8.4K |
| Jan 27, 2024 | ORBIMED ADVISORS LLC | Director, 10% Owner | Purchase | 3.1M | $2.40 | $7.5M |
| Jan 27, 2024 | Carl L Gordon | Director, 10% Owner | Purchase | 3.1M | $2.40 | $7.5M |
| Jun 30, 2023 | Steve Dubin | Director | Purchase | 5.0K | $2.40 | $12.0K |
| Jun 29, 2023 | Carl L Gordon | Director, 10% Owner | Purchase | 875.0K | $2.09 | $1.8M |
| Jun 29, 2023 | Erez Chimovits | Director, 10% Owner | Purchase | 875.0K | $2.09 | $1.8M |
| Feb 18, 2023 | Don Healey | Chief Technology Officer | Sale | 4.5K | $7.57 | $34.3K |
| Feb 14, 2023 | Don Healey | Chief Technology Officer | Sale | 10.5K | $7.98 | $83.5K |
| Nov 15, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 7.0K | $21.00 | $146.3K |
| Nov 15, 2022 | Chen Schor | President & CEO | Sale | 40.0K | $20.30 | $811.2K |
| Nov 9, 2022 | Chen Schor | President & CEO | Sale | 30.0K | $19.05 | $571.5K |
| Nov 4, 2022 | Chen Schor | President & CEO | Sale | 25.3K | $18.04 | $456.7K |
| Oct 21, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 8.1K | $16.27 | $131.3K |
| Oct 14, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 1.6K | $15.40 | $25.3K |
| Sep 16, 2022 | Chen Schor | President & CEO | Sale | 952 | $18.00 | $17.1K |
| Sep 13, 2022 | Chen Schor | President & CEO | Sale | 78.4K | $16.80 | $1.3M |
| Aug 5, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 7.0K | $18.00 | $125.4K |
| Aug 3, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 7.0K | $16.64 | $115.9K |
| Jul 7, 2022 | Blake Aftab | Chief Scientific Officer | Sale | 1.4K | $14.50 | $19.8K |
| Apr 5, 2022 | Francesco Galimi | SVP & Chief Medical Officer | Sale | 15.6K | $21.00 | $327.6K |
| Mar 11, 2022 | Aya Jakobovits | Director | Sale | 4.0K | $14.00 | $56.0K |
| Feb 17, 2022 | Aya Jakobovits | Director | Sale | 4.0K | $14.83 | $59.3K |
Showing the 25 most recent of 44 Form 4 filings for Adicet Bio, Inc..
Most active ACET insiders
- Chen Schor14 filings
- Aya Jakobovits6 filings
- Blake Aftab6 filings
- ORBIMED ADVISORS LLC4 filings
- PureTech Health LLC4 filings
Ask anything about ACET insider activity
Use Trabud's AI agent to query Adicet Bio, Inc.'s Form 4 history in plain English — "Show me ACET CEO purchases this year" or compare it against any other ticker.
Open the AI agentACET insider trading FAQ
Are Adicet Bio, Inc. insiders buying or selling?
Across 44 SEC Form 4 filings, Adicet Bio, Inc. (ACET) insiders reported 9 open-market purchases totaling $39.3M and 35 sales totaling $16.9M. That is a net buying position of $22.4M.
How many insiders trade ACET stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Adicet Bio, Inc.. The most recent filing was accepted on Apr 13, 2026.
Where does Trabud get ACET insider trading data?
All ACET insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.